WHO ICTRP trial
Comparative study of the effects on L-dopa formulation absorption by the acid…
JPRN-UMIN000016659 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000016659 |
|---|---|
| Public title | Comparative study of the effects on L-dopa formulation absorption by the acid secretion inhibitor |
| Scientific title | Comparative study of the effects on L-dopa formulation absorption by the acid secretion inhibitor - Comparative study of the effects on L-dopa formulation absorption by the acid secretion inhibitor |
| Primary sponsor | Utano National Hospital, National Hospital Organaization |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase I |
| Countries | Japan |
| Conditions | healty adult Parkinson's disease |
| Interventions | MENESIT100 1tablet once a day (p.o.) famotidine 40mg/day for previous 1day (p.o.) MENESIT100 1tablet once a day (p.o.) esomeprazole 20mg for previous three days or more (p.o.) MENESIT100 1tablet once a day (p.o.) |
| Registration date | Jan 3, 2015 |
| Target size | 3 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: